ABCWINRisk and Statistics1 Risk and Statistics Risk Assessment in Clinical Decision Making Ulrich Mansmann Medical Statistics Branch University of Heidelberg.

Slides:



Advertisements
Similar presentations
Agency for Healthcare Research and Quality (AHRQ)
Advertisements

CRITICAL THINKING The Discipline The Skill The Art.
Comparator Selection in Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research and Quality (AHRQ)
Participation Requirements for a Patient Representative.
Rulebase Expert System and Uncertainty. Rule-based ES Rules as a knowledge representation technique Type of rules :- relation, recommendation, directive,
PROFESSIONAL NURSING PRACTICE
Copyright © 2012 Pearson Education Chapter 5 Individual Perception and Decision- Making 5-1 Essentials of Organizational Behavior, 11/e Global Edition.
Clinical Decision Making Clinicians are prone to a wide range of cognitive errors and biases in clinical judgment situations.  Only by being aware of.
Participation Requirements for a Guideline Panel PGIN Representative.
Decision Analysis Prof. Carl Thompson
The process of formulating responses remains
Perception and Individual Decision Making
Evidence-Based Medicine Week 3 - Prognosis Department of Medicine - Residency Training Program Tuesdays, 9:00 a.m. - 11:30 a.m., UW Health Sciences Library.
INTRODUCTION HINF 371 Medical Methodologies Session 1.
Judgment - Discussion HINF Medical Methodologies Session 8.
Michael Rawlins Chairman, National Institute for Health and Clinical Excellence, London Emeritus Professor, University of Newcastle upon Tyne Honorary.
Risk Management and Strategy Prioritisation Intelligence Step 8 - Risk Management and Strategy Prioritisaiton Considering the risks associated with action.
Documentation for Acute Care
By Dr. Ahmed Mostafa Assist. Prof. of anesthesia & I.C.U. Evidence-based medicine.
Baltic Dental Meeting Palanga Dana Romane The Patient in the Centre – Patient’s Involvement in the Treatment Process, Full Awareness and.
Clinical Practice Guidelines
Chapter 17 Nursing Diagnosis
The Bahrain Branch of the UK Cochrane Centre In Collaboration with Reyada Training & Management Consultancy, Dubai-UAE Cochrane Collaboration and Systematic.
Multiple Choice Questions for discussion
EPISODES, CONTEXTS, AND INTERCULTURAL INTERACTIONS
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 14 Screening and Prevention of Illnesses and Injuries: Research Methods.
Dr.F Eslamipour DDS.MS Orthodontist Associated professor Department of Oral Public Health Isfahan University of Medical Science.
Research Study Design. Objective- To devise a study method that will clearly answer the study question with the least amount of time, energy, cost, and.
Evidence-Based Public Health Nancy Allee, MLS, MPH University of Michigan November 6, 2004.
How to Analyze Therapy in the Medical Literature (part 2)
Understanding real research 4. Randomised controlled trials.
Finding Relevant Evidence
Vanderbilt Sports Medicine Chapter 5: Therapy, Part 2 Thomas F. Byars Evidence-Based Medicine How to Practice and Teach EBM.
Evidence-based shared decision-making (EB SDM) A neglected research topic David L. Hahn, M.D., M.S. (Epidemiology) Dept. Family Practice, Dean Medical.
Literature Appraisal Effectiveness of Therapy. Measures of treatment effect Statistical significance Odds ratio Relative risk Absolute risk reduction.
Lecture 9: Analysis of intervention studies Randomized trial - categorical outcome Measures of risk: –incidence rate of an adverse event (death, etc) It.
1 Updates on Regulatory Requirements for Missing Data Ferran Torres, MD, PhD Hospital Clinic Barcelona Universitat Autònoma de Barcelona.
CAUSALITY ASSESSMENT OF SUSPECTED AEs Dr. Retesh Kumar Head, Global PhV Department 12/13/2015.
1 Study Design Issues and Considerations in HUS Trials Yan Wang, Ph.D. Statistical Reviewer Division of Biometrics IV OB/OTS/CDER/FDA April 12, 2007.
Introduction.
Decision Analytic Approaches for Evidence-Based Practice M8120 Fall 2001 Suzanne Bakken, RN, DNSc, FAAN School of Nursing & Department of Medical Informatics.
Organization of statistical research. The role of Biostatisticians Biostatisticians play essential roles in designing studies, analyzing data and.
Criteria for selection of a data collection instrument. 1.Practicality of the instrument: -Concerns its cost and appropriateness for the study population.
1 DECISION MAKING Suppose your patient (from the Brazilian rainforest) has tested positive for a rare but serious disease. Treatment exists but is risky.
EVALUATING u After retrieving the literature, you have to evaluate or critically appraise the evidence for its validity and applicability to your patient.
BIOSTATISTICS Lecture 2. The role of Biostatisticians Biostatisticians play essential roles in designing studies, analyzing data and creating methods.
EBM --- Journal Reading Presenter :葉麗雯 Date : 2005/10/27.
Decision Science Brian J Wells, MD, PhD. Wake Forest Baptist Medical Center Humans are poor decision makers when chance is involved and we frequently.
Who is involved in making NICE guidance recommendations and what evidence do they look at? Jane Cowl, Senior Public Involvement Adviser Tommy Wilkinson,
Established standards of care given with respect and consideration, regardless of race, age, or payment source. Information about your illness, possible.
EVIDENCE-BASED MEDICINE AND PHARMACY 1. Evidence-based medicine 2. Evidence-based pharmacy.
Methodological Issues in Implantable Medical Device(IMDs) Studies Abdallah ABOUIHIA Senior Statistician, Medtronic.
Article Title Resident Name, MD SVCH6/13/2016 Journal Club.
Critical Appraisal of a Paper Feedback. Critical Appraisal Full Reference –Authors (Surname & Abbreviations) –Year of publication –Full Title –Journal.
Copyright © 2010, 2006, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 10 Evidence-Based Practice Sharon E. Lock.
Medicines adherence Implementing NICE guidance 2009 NICE clinical guideline 76.
Evidence-Based Mental Health PSYC 377. Structure of the Presentation 1. Describe EBP issues 2. Categorize EBP issues 3. Assess the quality of ‘evidence’
2 3 انواع مطالعات توصيفي (Descriptive) تحليلي (Analytic) مداخله اي (Interventional) مشاهده اي ( Observational ) كارآزمايي باليني كارآزمايي اجتماعي كارآزمايي.
Medical Necessity Criteria An Overview of Key Components Presented by BHM Healthcare Solutions.
Evidence-based Medicine
1st International Online BioMedical Conference (IOBMC 2015)
8. Causality assessment:
Prescribing.
Evidence-Based Medicine
Strategies to incorporate pharmacoeconomics into pharmacotherapy
9. Introduction to signal detection
Chapter 7 The Hierarchy of Evidence
Communication Skills Lecture 1-2
remember to round it to whole numbers
Level of Evidence Lecture 4.
Presentation transcript:

ABCWINRisk and Statistics1 Risk and Statistics Risk Assessment in Clinical Decision Making Ulrich Mansmann Medical Statistics Branch University of Heidelberg

ABCWINRisk and Statistics2 Risk Definition: The probability that a particular adverse event occurs during a stated period of time as result from a particular challange. Focus: Risks to patients in the clinical setting Events of occuring physical harm due to therapeutic interventions

ABCWINRisk and Statistics3 Not of interest Risk to caregivers Risk to a health system Risk to an insurance company

ABCWINRisk and Statistics4 Facts that modulate risk assessment and clinical decisions Clinical decisions are made because it is believed that the actions that follow them will do more good than harm. Risk assessment depends on the circumstances or the context in which decisions are made: - values - preferences - information availble

ABCWINRisk and Statistics5 Ability to assess risk efficiently in different circumstances, in conjunction with values Aware of relevant information Access to relevant information Availability of information in an intellectually accessible way Ability to interpret information Skills to incorporate information into decision making

ABCWINRisk and Statistics6 Balancing risks and benefits Consider alternative actions (including doing nothing) Knowledge of beneficial effects - RCT Knowledge of risks: - RCT may be not appropriate - comes from other types of studies: Cohort Studies Case-Control Studies other sources (usually less valid)

ABCWINRisk and Statistics7 Components of Risk Assessment Risk estimation Risk communication Risk perspective Risk acceptance Formal decision making procedures

ABCWINRisk and Statistics8 Risk estimation Quantification of risks: - measures of risks Sources of risks: - patient related - disease related - treatment related

ABCWINRisk and Statistics9 Risk Estimation: Measures of Risk Absolute risk Relative risk NNT (number needed to treat) Number of treatment years to produce an adverse event

ABCWINRisk and Statistics10 Risk Estimation: Measures of Risk Precision  sample size Validity (unbiased)  study design Reliability  study design Limitations in definition, attribution, recording, identification, classification, reporting, measurement, and analysis of risk information.

ABCWINRisk and Statistics11 Example: Helsinki Heart Study Cardiac event within 5 years YESNO Placebo Gemfibrozil Risk Placebo: 84/2030 ~ 4.14%RR = 2.73/4.14 = 0.66 Risk Gemfibrozil: 56/2051 ~ 2.73% Absolute risk reduction:4.14% % = 1.41% Relative risk reduction:1.41% / 4.14% = 0.34 (34%) NNT: 100 treated  1.41 prevented, 71 treated  1 prevented Yearly risks:Placebo: /5 = (0.83%) Gemfibrozil: /5 = (0.55%)

ABCWINRisk and Statistics12 Risk communication The type of risk estimates presented to decision makers affects their assessment of risk. absolute risk reduction versus relative risk reduction How risk estimates are described influences the reaction of those given the information. Describing the effect of an anti-cancer drug in terms of survivors or in terms of deaths (HDT for breats cancer)

ABCWINRisk and Statistics13 Risk communication Graphical Displays Do they facilitate data interpretation? Patients and clinicians interprete the same display differently. No guidance for the selection of graphical displays to communicate risk information. There is no simple best method to present information to decision makers.

ABCWINRisk and Statistics14 Risk communication Graphical Displays: KM curves patients clinicians

ABCWINRisk and Statistics15 Risk perception probability associated with the event decision weights prior beliefs, experience ability to interprete intuitive rule of thumb suspicion of vested interest Even if decision makers are presented with accurate estimates in multiple forms, their perception may be influenced by:

ABCWINRisk and Statistics16 Risk perception probability value Quantity of live Quality of live Survival rate of cancer patient > 50% < 50%

ABCWINRisk and Statistics17 Quick decisions, usually in the absence of strong supporting evidence. Opinions once formed are slow to change in response to new evidence. Evidence is handled in an asymmetric way by clinicians as well as patients. Risk perception prior beliefs and experience

ABCWINRisk and Statistics18 Risk perception ability to interprete probabilistic information Exaggerated reliance on vivid experiences or anecdotes. Lack of formal training in statistics. Patients have limited ability to interprete scientific evidence. Studies show: physicians overestimate risk. Training in judgements on disease probabilities results in no change in treatment decisions.

ABCWINRisk and Statistics19 Risk perception heuristics Situations with full informations from RCTs or observational studies do seldom exist. Despite lack of evidence clinicians are forced to make decisions. Patients use heuristics to reduce complexity of the problem. Needed: Studies on heuristics.

ABCWINRisk and Statistics20 Risk perception additional factors Implications of the decision Type of Outcome Timing between decision and outcome Circumstances Role

ABCWINRisk and Statistics21 Formal decision making procedures Standard gamble Time trage off Utilities Willingness to pay Helping a patient to reach a decision by attempting to incorporate risks, benefits, but also values, and preferences of the patient.

ABCWINRisk and Statistics22 Conclusions Medical statistics is primarily concerned with providing accurate estimates of risks in clinical situations. Decision making following the estimates of risks depends on more than just the risks (benefits) involved. Research needed on: Risk communication, perception, and acceptance. Necessary to harmonize the decision making process between patients and clinicians.

ABCWINRisk and Statistics23 Final Remark Human values, different for each of us, influence our perceptions in such complex ways that at no time will all of us agree on a single level of acceptable risk. But if people can agree upon the way risks are measured, and on the relevance of the levels of risk thus represented to the choices we must make, then the scope of disagreement and dissent is hereby limited.

ABCWINRisk and Statistics24 Slides available: